Perfusion Imaging Evaluation for Ischemic Stroke on 6-24 Hours Undergoing Endovascular Thrombectomy

Recruiting N/A Interventional Study
Stroke, Acute Cerebral Infarction
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
55 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to evaluate the hypothesis that thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days as compared to medical management alone in appropriately selected subjects with the Target Mismatch Profile and an MCA (M1 and M2 segment) or ICA occlusion or BA who have endovascular thrombectomy initiated between 6-24 hours …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Clinical Inclusion Criteria: 1. Clinical signs and symptoms consistent with the diagnosis of an acute ischemic stroke 2. Age ≥18 years 3. NIHSS ≥ 6 4. Endovascular thrombectomy can be initiated (femoral puncture) between 6 and 24 hours after time last know well 5. No significan…
Contacts

MIN LOU, Ph.D.

8657187784811

loumingxc@vip.sina.com

CONTACT